Dr Salome Charalambous is the research director at the Aurum Institute.
Her training includes a medical degree from Wits University and a MSc and PhD in Epidemiology at the London School of Hygiene and Tropical Medicine.
She has an interest and experience in medical research in the fields of HIV and TB. She was involved in HIV programme implementation prior to anti-retroviral therapy implementation in the mining industry and was instrumental in the first large anti-retroviral implementation project in the Anglo American companies. Following that, she was the main recipient of a large PEPFAR grant which involved HIV programme implementation in settings with private practitioners, public sector hospitals, such as Chris Hani Baragwanath hospital, and Thembisa hospital, and the Department of Corrections. As part of programme implementation, she also conducted research studies and published articles on TB-HIV integration, HIV programme evaluations and other topics related to HIV and TB. She is currently the Principal Investigator on a number of clinical trials and large cluster-randomized epidemiological studies including TB Fast Track (TB treatment initiation on ART patients) and TB MERGE (TB HIV integration project).